Follow us on Twitter
twitter icon@FreshPatents


Wound Healing patents

      

This page is updated frequently with new Wound Healing-related patent applications.




 System and  wound healing patent thumbnailSystem and wound healing
A system is provided for healing a wound. The system includes a flexible body, a therapeutic agent delivery mechanism, a suction mechanism, and a power source.
The Cleveland Clinic Foundation


 Biophotonic compositions and methods for providing biophotonic treatment patent thumbnailBiophotonic compositions and methods for providing biophotonic treatment
The present disclosure provides biophotonic topical compositions and methods useful in phototherapy. In particular, the biophotonic topical compositions of the present disclosure are substantially resistant to leaching such that very low amounts of chromophore(s) present in the biophotonic composition leach out of the composition.
Klox Technologies Inc.


 Method and  noninvasive inhibition of deep vein thrombosis patent thumbnailMethod and noninvasive inhibition of deep vein thrombosis
System, device and method for providing neuromuscular electrical stimulation (nmes) to muscles of foot. The device includes an electrical signal generator for producing a wave pattern of variable frequency, duration, intensity, ramp time and on-off cycle.
Stimmed Llc


 Method for promoting wound healing by administering a compound which binds ldl-receptor-related protein (lrp) ligand binding domain patent thumbnailMethod for promoting wound healing by administering a compound which binds ldl-receptor-related protein (lrp) ligand binding domain
The present invention relates to the field of therapeutic methods, compositions and uses thereof, that affect, directly or indirectly, the behavior of lrp receptors. These compositions and methods result in the treatment of inflammatory, immunological and metabolic conditions.
Enzo Biochem, Inc.


 Magnesium/polymer composite-containing scaffolds to enhance tissue regeneration patent thumbnailMagnesium/polymer composite-containing scaffolds to enhance tissue regeneration
The invention relates to magnesium-polymer composites, methods for their preparation and applications for their use. The composites include a combination of magnesium particles and polymer matrix.
University Of Pittsburgh-of The Commonwealth System Of Higher Education


 Composition and  enhancing wound healing patent thumbnailComposition and enhancing wound healing
The invention relates to a composition for enhancing wound healing and/or for reducing pain and inflammation, comprising a first active ingredient and a second active ingredient, wherein the first active ingredient comprises an antiseptic and the second active ingredient comprises an admixture of at least one vitamin, at least one mineral and at least one amino acid, and to use of the composition for enhancing wound healing.. .

 Ferment extract of a bacterial strain for the increase of adiponectin levels patent thumbnailFerment extract of a bacterial strain for the increase of adiponectin levels
A ferment extract of a bacterial strain of the bacillus pumilus species, a method of treatment and/or care of the skin and/or muscles, and cosmetic and/or dermopharmaceutical compositions containing the ferment extract. In particular, the ferment extract is used for muscular endurance, wound healing and skin firmness..
Lubrizol Advanced Materials, Inc


 Dissection handpiece and  reducing the appearance of cellulite patent thumbnailDissection handpiece and reducing the appearance of cellulite
A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
Ulthera, Inc.


 Wound cleansing apparatus in-situ patent thumbnailWound cleansing apparatus in-situ
An apparatus for cleansing wounds, in which wound exudate is removed from a wound bed and selectively cleansed and returned to the wound. The cleansing means removes materials deleterious to wound healing, and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned to the wound bed.
Smith & Nephew Plc


 Compositions and methods to promote wound healing patent thumbnailCompositions and methods to promote wound healing
Compositions and methods to promote wound healing are described. The compositions and methods up-regulate x-box binding protein 1 (xbp1) and/or inositol-requiring enzyme-1 (ire-1).
Wayne State University


Method and system for extracting and using moomiyo compositions

A method and system for extraction of moomiyo from a multi-component, naturally-occurring mineral substance generally found in asian mountain ranges at elevations approximately between 1000 and 5000 meters. Bio-active compounds are extracted from said mineral substance for the medicinal applications including at least one of joint pain relief, skin care, anti-inflammation, bruise removal, decrease high blood cholesterol and high triglycerides levels, promotion of mental and physical energy, regulation of blood sugar levels, stimulation of the immune system, speeding of the recovery from sickness and wound healing therapies..

Novel ultrashort hydrophobic peptides that self-assemble into nanofibrous hydrogels and their uses

The present invention relates to hydrophobic peptides and/or peptidomimetics capable of forming a (nanofibrous) hydrogel and hydrogels comprising said hydrophobic peptides and/or peptidomimetics and to various uses, such as in regenerative medicine, injectable therapies, delivery of bioactive moieties, wound healing, 2d and 3d synthetic cell culture substrate, biosensor development, biofunctionalized surfaces, and biofabrication.. .
Agency For Science, Technology And Research

Cross-linked dehydrated placental tissue grafts and methods for making and using the same

Described herein are tissue grafts produced by contacting dehydrated placental tissue grafts with a cross-linking agent. The tissue grafts described herein provide barrier and prevent the migration of a bioactive agent from the wound.
Mimedx Group, Inc.

Wound healing composition

The present invention relates to compositions for use in pharmaceutical, cosmetic and cosmeceutical applications, particularly wound healing, including the treatment of lesions and burns. In particular, the present invention relates to compositions comprising platelet enriched plasma (prp) and stem cell conditioned medium (sc cm) for use in pharmaceutical, cosmetic and cosmeceutical applications such as wound healing..

Short bio-active peptides for promoting wound healing

Peptides having four to six amino acid residues are disclosed that possess biological activity. These peptides constitute short fragments of the peptide hb-107 (mpkekvflkiekmgrnirn) (seq id no: 10), which itself is a fragment of the antimicrobial protein cecropin b, and exhibit cell stimulatory and migratory properties.
Helix Biomedix, Inc.

Polypeptide, dna molecule encoding the polypeptide, vector, preparation method and use

A polypeptide, a dna molecule encoding the polypeptide, a vector, a preparation method and a use therefor are disclosed. The polypeptide comprises an amino acid sequence represented by formula (i) or formula (ii): formula (i) comprises an amino acid sequence represented by seq id no: 1; formula (ii) comprises an amino acid sequence obtained by subjecting the amino acid sequence represented by seq id no: 1 to modification, substituted, and deletion or addition of one or more amino acids.
Wuhan More Biotechnology Co., Ltd.

Flowable collagen-based hemostat and methods of use

The invention relates to methods for fabricating a flowable hemostatic composition. The invention also relates to hemostatic compositions and methods for promoting wound healing.
Orthovita, Inc.

Functional nanoparticle composite comprising chitosan

Methods for producing economical antimicrobial and antifungal nanoparticle composites are presented. The method includes converting chitosan or derivative thereof to nanoparticles by ionotropic gelation process and the nanoparticle composite in the presence of a process solution without any separation process to isolate the nanoparticles prior to application.
Water Security Corporation

Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids

This invention is in the field of medicinal chemistry and relates to novel compounds, and pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of fibrotic diseases including scleroderma, systemic sclerosis, scleroderma-like disorders, sine scleroderma, liver cirrhosis, interstitial pulmonary fibrosis, dupuytren's contracture, keloids, chronic kidney disease, chronic graft rejection, and other scarring/wound healing abnormalities, post operative adhesions, and reactive fibrosis. The invention also relates to methods of using the compounds and pharmaceutical compositions of this invention to treat fibrotic conditions..
Corbus Pharmaceuticals Inc.

Promotion of lymphatic function

The present invention refers to lipophilic extracts of members of the iridaceae family, such as iris germanica and/or iris pallida, that have been found to promote lymphatic function. These extracts are suitable for the treatment of skin inflammation, rheumatoid arthritis, impaired wound healing, chronic inflammatory diseases, chronic airway inflammation, inflammatory bowel disease, rosacea, primary and/or secondary lymphedemas.
Eth Zuerich

Biomaterial compositions, implants, and methods of making the same

Biomaterials, implants made therefrom, methods of making the biomaterial and implants, methods of promoting bone or wound healing in a mammal by administering the biomaterial or implant to the mammal, and kits that include such biomaterials, implants, or components thereof. The biomaterials may be designed to exhibit osteogenic, osteoinductive, osteoconductive, and/or osteostimulative properties..
Globus Medical, Inc.

Biomaterial compositions, implants, and methods of making the same

Biomaterials, implants made therefrom, methods of making the biomaterial and implants, methods of promoting bone or wound healing in a mammal by administering the biomaterial or implant to the mammal, and kits that include such biomaterials, implants, or components thereof. The biomaterials may be designed to exhibit osteogenic, osteoinductive, osteoconductive, and/or osteostimulative properties..
Globus Medical, Inc.

Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms

The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them.
Fred Hutchinson Cancer Research Center

Use of citrus polyphenol for wound healing and composition thereof

The present invention provides a composition for wound healing, which includes an effective amount of a citrus polyphenol. Moreover, the present invention also provides a method for improving wound healing and improving fibroblasts migration and/or proliferation, which includes applying an effective amount of citrus polyphenol to the wound and fibroblasts..
National Taiwan University

Antimicrobials and methods of use thereof for wound healing

This disclosure provides generally for antimicrobial compositions and methods of use comprising an anthocyanin, an anthocyanidin or metabolites thereof. Methods for promoting healing of a wound using these compositions are also disclosed.

Therapeutic and cosmetic uses and applications of calreticulin

The invention relates to therapeutic and cosmetic uses of calreticulin including reducing or eliminating wrinkles and/or fine lines, tissue repair and reconstruction, repairing damaged bone and/or cartilage, stimulating regeneration of an epidermal appendage, enhancing phagocytosis of bacteria by phagocytes within a wound, treating a wound in a patient suffering from delayed wound healing, treating a corneal wound, and treating or preventing a surgical adhesion.. .
Calregen Inc.

Olivamine-induced improvement in endothelial cells viability and function

Compositions for and methods of improving wound healing are disclosed, including compositions for and methods of treating chronic wounds, and compositions for the inhibition and treatment of necrosis and extended quiescence that result in cellular necrosis instead of normal proliferation. The compositions include hydroxytyrosol, oleuropein, or a combination of hydroxytyrosol and oleuropein with endothelial cells.

Synthetic platelets

Provided herein are various functionalized particles comprising a shell, dendritic linkers, and functional moieties. The dendrimer linkers allow very large numbers of functional moieties to be bound to the shell.
The Regents Of The University Of California

Methods for promoting wound healing

The present invention provides methods for promoting wound healing or treating dermal radiation injury by the use of a gel formulation comprising about 0.5% to about 4% hydroxyethyl cellulose (hec) on a weight (mg)/volume (ml) basis, or on a weight/weight (mg) basis.. .
University Of Southern California

Hemostatic fabric

Disclosed herein are hemostatic fabrics that include agents, including metal fibers or powders, that can control bleeding and contribute to faster wound healing.. .

Wound healing compositions and treatments

This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase..
Coda Therapeutics, Inc.

Wound healing

A method of treating a chronic wound in a subject in need of such treatment is provided. The method includes administering to the subject at least one antioxidant agent in an amount effective to treat the wound.
The Regents Of The University Of California

Pro-angiogenic peptides and peptide conjugates

Short bioactive sequences derived from the 2nd loop of the 7-transmembranal receptor of endothelial differentiation gene 3 (edg3) useful in stimulation of angiogenesis, and peptide conjugates comprising a permeability enhancing moiety, are provided. Also provided are pharmaceutical compositions comprising the peptides and methods of use in conditions were insufficient blood-supply occurs, or which are associated with endothelia dysfunction such as peripheral vascular diseases, coronary artery diseases, cerebrovascular diseases, diabetes and delayed wound healing, pulmonary disease, eye diseases and pathological condition related to severe infection..
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.

Wet wound dressing

A wet wound dressing is formed from hydrophilic polyurethane foam. The hydrophilic polyurethane foam is formed by the foaming process using a hydrophilic polyurethane material and a foaming agent.
Taicend Technology Co., Ltd

Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides

Sterilized wound healing compositions comprise stabilized cyanoacrylate monomers homogenously mixed together with a naphthoquinone 2,3-oxide, including vitamin k oxides. The compositions are sterilized by irradiation, and the sterilized compositions are shelf stable such that their viscosity does not substantially increase following at least two years of shelf storage.
Adhezion Biomedical, Llc

Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase

The present invention relates to compounds of the formula (i), wherein r1, r2, r3, r4 and x have the meanings indicated in the claims. The compounds of formula i are valuable pharmacologically active compounds.
Sanofi

Composite synthetic nanofibrous scaffolds and articles thereof

A synthetic scaffold that comprises a population of nanofibers that include collagen and an anti-thrombotic glycan is provided. In addition, a method of making the synthetic scaffold is provided.
3m Innovative Properties Company

Biomedical device

The present invention is related to a patterned membrane comprising nanofibrillar polysaccharides, device and compositions for improving wound healing, as well as to their manufacture and use for therapy.. .
Upm-kymmene Corporation

Patterned membrane

The present invention is related to a patterned membrane comprising nanofibrillar polysaccharides, device and compositions for improving wound healing, as well as to their manufacture and use for therapy.. .
Upm-kymmene Corporation

Polyhydroxyalkanoate medical textiles and fibers

Absorbable polyester fibers, braids, and surgical meshes with prolonged strength retention have been developed. These devices are preferably derived from biocompatible copolymers or homopolymers of 4-hydroxybutyrate.
Tepha, Inc.

Method of treating wounds

The present disclosure provides a method of treating wound healing in a subject, the method comprising administering to the subject a compound that inhibits vegf-b signalling.. .
B-creative Sweden Ab

Substituted piperidinyl-tetrahydroquinolines

The present application relates to novel substituted piperidinyltetrahydroquinolines, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardial vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, raynaud's phenomenon, crest syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.. .
Bayer Pharma Aktiengesellschaft

Substituted bipiperidinyl derivatives

The invention relates to novel substituted bipiperidinyl derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardiac vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, raynaud's phenomenon, crest syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.. .
Bayer Pharma Aktiengesellschaft

Multi-component electrospun fiber scaffolds

A scaffold may comprise a first polymeric electrospun fiber comprising a first material having a first degradation rate, and a second polymeric electrospun fiber comprising a second material having a second degradation rate different from the first degradation rate. The first degradation rate may substantially correspond to a cell infiltration rate, and the second degradation rate may be slower than the first degradation rate.
Nanofiber Solutions, Inc.

Composition and dressing for wound treatment

The invention provides methods and compositions for wound treatment and/or blood clot formation, e.g., arresting the flow of blood from an open wound. The methods and compositions provide for promoting and accelerating wound healing and optionally provide for inhibition of microbial infection and/or a local analgesic effect..
Protege Biomedical, Llc

Drug delivery devices and growth factor formulations for accelerated wound healing

The present invention is directed to novel drug delivery devices and pharmaceutical compositions containing growth and differentiation factor proteins. Said devices and compositions are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues.
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh

Method for wound healing

The present invention relates generally to methods and compositions for promoting wound healing in a subject. In particular, the invention relates to the use of ingenol compounds, particularly ingenol angelates, in wound healing and compositions thereof which contain such compounds..
Leo Laboratories Limited

Methods for the synthesis of ceragenins

Disclosed herein are methods of making ceragnenin compounds for treating, preventing, or diagnosing diseases, disorders, or conditions associated with bacterial or viral infections, cancer, inflammation, and osteogenesis. Ceragenin compounds display broad-spectrum antibacterial activity utilizing a mode of action similar to antimicrobial peptides, but without the high synthesis costs and susceptibility to proteolytic degradation.
Brigham Young University

Methods for the synthesis of ceragenins

Disclosed herein are methods of making ceragnenin compounds for treating, preventing, or diagnosing diseases, disorders, or conditions associated with bacterial or viral infections, cancer, inflammation, and osteogenesis. Ceragenin compounds display broad-spectrum antibacterial activity utilizing a mode of action similar to antimicrobial peptides, but without the high synthesis costs and susceptibility to proteolytic degradation.
Brigham Young University

Infusion set adhesive systems

Improvements in an adhesive patch for an infusion set include the addition of an antiperspirant, wound healing and/or antimicrobial agent to the adhesive surface, and the layering of different backing materials to improve performance characteristics of the patch. Patches may be offered as part of a product line, in which differently shaped patches are provided for attachment to different parts of the body, and different pressure sensitive adhesives provide different peel strength according to different use patterns of the end user..
Becton, Dickinson And Company

Compositions and methods to diagnose diabetes and/or to treat negative effects of diabetes

The present disclosure describes a genome-wide transcriptional analysis of differentially expressed genes in diabetic, non-diabetic, normal and wounded tissue. The analysis allowed development of compositions and methods to diagnose diabetes and/or to treat negative effects of diabetes, including delayed wound healing and reduced vision..
Wayne State University

Tilapia piscidins for use in enhancement of wound healing

The preset invention relates to a new method for enhancing wound healing comprising administering a subject in need thereof with a therapeutically effective amount of a tilapia piscidin (tp), which is selected from the group consisting of tp1, tp2, tp3, tp4, tp5 and combination thereof. A composition or pharmaceutical composition comprising the tp are also provided..
National Taiwan Ocean University

Uses of kappa opioid synthetic peptide amides

The invention relates to methods of use of synthetic peptide amides that are ligands of the kappa opioid receptor in the treatment and prevention of kappa opioid receptor-associated diseases and conditions; and particularly to uses of these agonists in the prophylaxis, inhibition and treatment of pain, inflammation and pruritis associated with a variety of diseases, disorders and conditions. Inflammatory conditions preventable or treatable by the methods of the invention include diseases and conditions associated with elevated levels of a proinflammatory cytokines, such as tnf-α, il-1β, il-6, mmp-1 and mmp-3.
Cara Therapeutics, Inc.

Methods and compositions for regenerating and repairing damaged or aged tissue or organs using nonviable irradiated or lyophilized pluripotent stem cells

Compositions and methods are provided herein for regenerating and repairing damaged or aged tissue or organs using nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods described herein provide anti-aging benefits to the skin by increasing the hydration reducing fine lines, wrinkles, and pores of the skin.

Methods of using regenerative cells to promote wound healing

Cells present in adipose tissue are used to promote wound healing in a patient. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells obtained from the adipose tissue to a patient.
Cytori Therapeutics, Inc.



Wound Healing topics:
  • Wound Healing
  • Amino Acid
  • Amino Acid Sequence
  • Proliferation
  • Theophylline
  • Inflammation
  • Antimicrobial
  • Epithelial
  • Amino Acids
  • Skin Graft
  • Bone Healing
  • Vascular Disease
  • Skin Ulcer
  • Bacterial Infection
  • Dysfunction


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Wound Healing for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Wound Healing with additional patents listed. Browse our RSS directory or Search for other possible listings.


    1.4557

    file did exist - 2692

    0 - 1 - 55